Copyright © 2015 Kristin Unthan et al.This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. As the number of donor hearts is limited while more and more patients suffer from end stage biventricular heart failure, Total ArtificialHearts become a promising alternative to conventional treatment.While pneumatic devices sufficiently supply the patients with blood flow, the patient’s quality of life is limited by the percutaneous pressure lines and the size of the external control unit. This paper describes the development of the control unit of the ReinHeart, a fully implantable Total Ar...
Objectives: Existing VADs are single-ventricle pumps needing anticoagulation. We developed a bi-vent...
With the incidence of end-stage heart failure steadily increasing, the need for a practical total ar...
Heart failure is a cardiovascular disease affecting between 1 and 2% of the population of developed ...
77 p.With increasing cardiovascular diseases and heart failures, heart transplantation has become a ...
Everyone knows heart is a vital organ. Your heart is the engine inside your body that keeps everythi...
Due to shortages in donor organ availability, advanced heart-failure patients are at high risk of fu...
According to the latest statistics published by the European Heart Network, cardiovascular diseases ...
Rotary blood pumps are emerging as a viable technology for total artificial hearts, and the developm...
Many patients with end-stage heart disease die because of the scarcity of donor hearts. A total arti...
This paper is to highlight the importance of medical technology in the area of Cardiovascular with t...
Heart failure (HF) affects an estimated 5.8 million Americans, accounting for near 250,000 deaths ea...
Two fields of cardiovascular energy harvesting are investigated, (1) stents and (2)leadless pacemake...
A total artificial heart (TAH) represents a challenge in medical science to provide a survival persp...
There are limited therapeutic options for final treatment of end-stage heart failure. Among them, im...
The optimal treatment option for end stage heart failure is transplantation; however, the shortage o...
Objectives: Existing VADs are single-ventricle pumps needing anticoagulation. We developed a bi-vent...
With the incidence of end-stage heart failure steadily increasing, the need for a practical total ar...
Heart failure is a cardiovascular disease affecting between 1 and 2% of the population of developed ...
77 p.With increasing cardiovascular diseases and heart failures, heart transplantation has become a ...
Everyone knows heart is a vital organ. Your heart is the engine inside your body that keeps everythi...
Due to shortages in donor organ availability, advanced heart-failure patients are at high risk of fu...
According to the latest statistics published by the European Heart Network, cardiovascular diseases ...
Rotary blood pumps are emerging as a viable technology for total artificial hearts, and the developm...
Many patients with end-stage heart disease die because of the scarcity of donor hearts. A total arti...
This paper is to highlight the importance of medical technology in the area of Cardiovascular with t...
Heart failure (HF) affects an estimated 5.8 million Americans, accounting for near 250,000 deaths ea...
Two fields of cardiovascular energy harvesting are investigated, (1) stents and (2)leadless pacemake...
A total artificial heart (TAH) represents a challenge in medical science to provide a survival persp...
There are limited therapeutic options for final treatment of end-stage heart failure. Among them, im...
The optimal treatment option for end stage heart failure is transplantation; however, the shortage o...
Objectives: Existing VADs are single-ventricle pumps needing anticoagulation. We developed a bi-vent...
With the incidence of end-stage heart failure steadily increasing, the need for a practical total ar...
Heart failure is a cardiovascular disease affecting between 1 and 2% of the population of developed ...